PottsJTJrDeftosLJ. Parathyroid hormone, calcitonin vitamin D, bone and bone mineral metabolism, In: BondyPKRosenbergLE, eds. Duncan's Diseases of Metabolism.Philadelphia: Saunders, 1974: 1225–1430.
2.
NordinBEC. Calcium, Phosphate and Magnesium Metabolism.Churchill Livingstone, 1976.
3.
HausslerMRMcCainTA. Basic and clinical concepts related to vitamin D metabolism and action. New Engl J Med1977; 297: 974–83 and 1041–50.
4.
SmithR.Biochemical Disorders of the Skeleton.Butterworths, 1979.
5.
BaileyJDErlichRMFraserDHowardN.Paediatric Endocrinology Medicine (3rd ser) 1978; 10: 465–84.
6.
LottJA. Determination of total and ionic serum calcium. CRC Critical Reviews in Analytical Chemistry1972; September: 41–64.
7.
PedersonKO. Protein bound calcium in human serum. Quantitative examination of binding and its variables by a molecular binding model and clinical chemical implications for measurement of ionised calcium. Scan J Clin Lab Invest1972; 30: 321–9.
LadensonJHLewisJWBoydJC. Failure of total calcium corrected for protein, albumin, and pH to correctly assess free calcium status. J Clin Endocrinol Metab1978; 46: 986–93.
12.
PayneRBLittleAJWilliamsRBMilnerJR. Interpretations of serum calcium in patients with abnormal serum proteins. Br Med J1973; 4: 643–6.
13.
BerryEMGuptaMMTurnerSJBurnsRR. Variations in plasma calcium with induced changes in plasma specific gravity, total protein and albumin. Br Med J1973; 4: 640–3.
14.
Buckley-SharpeMDTomlinsonSO'RiordanJLH. The parathyroids. Br J Hosp Med1978; 19: 40–53.
15.
RobertsonWG. Measurement of ionised calcium in body fluids—a review. Ann Clin Biochem1976; 13: 540–8.
16.
McLeanFCHastingsAB. Clinical estimation and significance of calcium ion concentrations in the blood. Am J Med Sci1935; 189: 601–13.
FitzgeraldF.Clinical hypophosphatemia. Ann Rev Med1978; 29: 177–89.
19.
CondonJRNassimJRRutterA.Defective intestinal phosphate absorption in familial and non familial hypophosphataemia. Br Med J1970; 3: 138–41.
20.
RasmussenHBordierP.The Physiological and Cellular Basis of Metabolic Bone Disease.Williams and Wilkins, 1974.
21.
MossDW. Enzyme tests in diseases of the bone. In: WilkinsonJH, ed. The Principles and Practice of Diagnostic Enzymology.London: Arnold, 1976: 399–422.
22.
PosenSCornishCKleerkoperM.Alkaline phosphatase and metabolic bone disorders. In AvioliLVKraneSM, eds. Metabolic Bone Disease.Vol. 1. Academic Press, 1977; 141–81.
23.
ClarkLCJrBeckE.Plasma ‘alkaline’ phosphatase activity 1. Normative data for growing children. J Pediat1950; 36: 335–41.
24.
WildingPRollasonJGRobinsonD.Patterns of change for various biochemical constituents detected in well populated screening. Clin Chim Acta1972; 41: 375–87.
25.
SharlandDEOverstallPW. Alkaline phosphatase: Changes in serum levels after a fracture. Br Med J1978; 1: 620.
26.
GoelKMSweetEMLoganRW. Florid and subclinical rickets among immigrant children in Glasgow. Lancet1976; 1: 1141–5.
27.
RasmussenHBartterFC. Hypophosphatasia. In: StanburyJBWyngaardenJBFredericksonDS, eds. The Metabolic Basis of Inherited Disease.4th ed.McGraw-Hill, 1978: 1340–50.
28.
AvioliLVHaddadJG. Vitamin D's: More and more measured better and better. N Engl J Med1977; 297: 1006–7.
29.
LambertPWSyversonBJArnaudCDSpelsbergTC. Isolation and quantitation of endogenous vitamin D and its physiologically important metabolites in human plasma by high pressure liquid chromatography. J Ster Biochem1977; 8: 929–37.
30.
FairneyATurnerCBaggioliniEGUskokovicMR. Development of a radioimmunoassay for vitamin D. In: NormanAWSchaeferKCoburnJWDeLucaHFFraserDGrigoleitHGHerrathDV, eds. Vitamin D Biochemical, Chemical and Clinical Aspects related to Calcium Metabolism.Berlin: de Gruyter, 1977: 459–61.
31.
HaddadJGJrChyuK.J.Competitive protein binding radioassay for 25-hydroxycholecalciferol. J Clin Endocr1971; 33: 992–5.
32.
StampTCBHaddadJGJrExton-SmithANReubenATwiggCA. Assay of vitamin D and its metabolites. Ann Clin Biochem1976; 13: 571–7.
33.
McLaughlinMFairneyALesterERaggattPRBrownDJWillsMR. Seasonal variations in serum 25 hydroxycholecalciferol in healthy people. Lancet1974; 1: 536–8.
34.
StampTCB. Intestinal absorption of 25 hydroxycholecalciferol. Lancet1974; 2: 121–3.
EismanJAHamstraAJKreamBEDeLucaHF. A sensitive precise and convenient method for determination of 1,25 dihydroxyvitamin D in human plasma. Arch Biochem Biophys1976; 176: 235–43.
37.
ClemensTLHendyGNGrahamRFBaggioliniEGUskikoviċMRO'RiordanJLH. A radioimmunoassay for 1,25 dihydroxycholecalciferol. Clin Sci Molec Med1978; 54: 329–32.
38.
ArnaudCDTsaoHSLittledikeT.Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest1971; 50: 21–34.
39.
FairneyAJacksonDClaytonBE. Measurement of serum parathyroid hormone, with particular reference to some infants with hypocalcaemia. Arch Dis Child1973; 48: 419–24.
40.
WoodheadJSWalkerDA. Assay of parathyroid hormone in human serum and its uses. Ann Clin Biochem1976; 13: 549–54.
41.
HabenerJFPottsJTJr.Biosynthesis of parathyroid hormone. N Engl J Med1978; 299: 580–5 and 635–44.
42.
DeftosLJBronzertDParthemoreJG. Diagnostic applications of calcitonin immunoassay. Ann Clin Lab Sci1974; 4: 484–6.
43.
SamaanNAAndersonGDAdam-MayneME. Immunoreactive calcitonin in the mother, neonate, child and adult. Am J Obstet Gynec1975; 121: 622–5.
44.
HeynenGFranchimontP.Human calcitonin radioimmune assay in normal and pathological conditions. Eur J Clin Invest1974; 4: 213–22.
45.
HillyardCJGreenbergPBCoombesRCMacIntyreILjungbergODymlingJF. Applications of a radioimmunoassay for human calcitonin. In: PasternakCA, ed. Radioimmunoassay in Clinical Biochemistry.Heyden. 1975: 245–52.
46.
TashjianAHJrVoelkelEFWolfeHJCalcitonin and prostaglandings: Significance, relevance and uncertainties in calcium regulating hormones. In: TalmageRVOwenMParsonsJA. eds. Calcium Regulating Hormones. Excerpta Medica. ICS 346; 1975: 135–48.
47.
DentCEWatsonL.The hydrocortisone test in primary and tertiary hyperparathyroidism. Lancet1968; 2: 662–4.
48.
MuradFPakCYC. Urinary excretion of adenosine 3′5′-monophosphate and guanosine 3′5′-monophosphate. N Engl J Med1972; 286: 1382–7.
49.
ChaseLRMelsonGLAurbachGD. Pseudohypoparathyroidism: Defective excretion of 3′, 5′-AMP in response to parathyroid hormone. J Clin Invest1969; 48: 1832–44.
50.
SmithLHVan den BergCJWilsonDM. Current concepts in nutrition—nutrition and urolithiasis. N Engl J Med1978; 298: 87–9.
51.
EpsteinFH. Time to cut for the stone. N Engl J Med1978; 298: 105–6.
52.
RoseGAHarrisonAR. The incidence, investigation and treatment of idiopathic hypercalciuria. Br J Urol1974; 46: 261–74.
53.
WillEJ. The management of renal stone disease. J R Coll Physicians, 1979; 13: 66–9.
54.
ByersPD. The diagnostic value of bone biopsies. In: AvioliLVKraneSM, eds. Metabolic Bone Disease.Vol. 1. Academic Press, 1977: 183–236.